Literature DB >> 18757191

Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder.

Schohraya Spahis1, Michel Vanasse, Stacey A Bélanger, Parviz Ghadirian, Emilie Grenier, Emile Levy.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most prevalent behavioral disorder in children and the pathophysiology remains obscure. In addition to the pharmacotherapy, which is the primary treatment of ADHD, nutritional intervention may have a significant impact on ADHD symptoms. We studied lipid and lipoprotein profiles, fatty acid (FA) composition, and oxidant-antioxidant status in 37 pediatric ADHD patients and 35 healthy control subjects. Our results show that plasma triacylglycerols and phospholipids were lower, whereas free cholesterol, HDL, and apolipoprotein A-I were higher in ADHD patients compared with controls. The proportion of plasma EPA and DHA was higher, but that of oleic and alpha-linolenic (ALA) acids was lower. As expected from these findings, the proportions of both total saturates and polyunsaturates fatty acids (PUFA) were higher and lower, respectively, in ADHD patients than in controls, which led to a significant decrease in the PUFAs/saturates ratio. On the other hand, the ratios of eicosatrienoic acid to arachidonic acid and of palmitoleic acid to linoleic acid, established indexes of essential fatty acid (EFA) status remained unchanged revealing that EFA did not affect ADHD patients. Similarly, the activity of delta-6 desaturase, estimated by the ratio of 18:2(n-6)/20:4(n-6), was found unaffected, whereas ALA/EPA was diminished. Lessened lipid peroxidation was noted in ADHD subjects as documented by the diminished values of plasma malondialdehyde accompanied by increased concentrations of gamma-tocopherol. In conclusions, significant changes occur in the lipid and lipoprotein profiles, as well as in the oxidant-antioxidant status of ADHD patients, however, the FA distribution does not reflect n-3 FA deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757191     DOI: 10.1016/j.plefa.2008.07.005

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  26 in total

1.  Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.

Authors:  Andreas Johannes Schmidt; Hans-Willi Clement; Stefan Gebhardt; Ulrich Michael Hemmeter; Eberhard Schulz; Jürgen-Christian Krieg; Tilo Kircher; Philip Heiser
Journal:  J Neural Transm (Vienna)       Date:  2010-05-14       Impact factor: 3.575

2.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

Review 3.  The potential of biomarkers in psychiatry: focus on proteomics.

Authors:  Izabela Sokolowska; Armand G Ngounou Wetie; Kelly Wormwood; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 4.  The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.

Authors:  Alessandra Tesei; Alessandro Crippa; Silvia Busti Ceccarelli; Maddalena Mauri; Massimo Molteni; Carlo Agostoni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-12-17       Impact factor: 4.785

5.  Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms.

Authors:  Chifu B Huang; Brian George; Jeffery L Ebersole
Journal:  Arch Oral Biol       Date:  2010-06-11       Impact factor: 2.633

6.  A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Authors:  Valérie Marcil; Emile Levy; Devendra Amre; Alain Bitton; Ana Maria Guilhon de Araújo Sant'Anna; Andrew Szilagy; Daniel Sinnett; Ernest G Seidman
Journal:  Inflamm Bowel Dis       Date:  2019-07-17       Impact factor: 5.325

7.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

8.  CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells.

Authors:  Geneviève Mailhot; Rémi Rabasa-Lhoret; Alain Moreau; Yves Berthiaume; Emile Levy
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

9.  Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study.

Authors:  Stacey Ageranioti Bélanger; Michel Vanasse; Schohraya Spahis; Marie-Pierre Sylvestre; Sarah Lippé; François L'heureux; Parviz Ghadirian; Catherine-Marie Vanasse; Emile Levy
Journal:  Paediatr Child Health       Date:  2009-02       Impact factor: 2.253

10.  Increased oxidative stress in children with attention deficit hyperactivity disorder.

Authors:  Hatice Sezen; Hasan Kandemir; Emin Savik; Sultan Basmacı Kandemir; Fethiye Kilicaslan; Hasan Bilinc; Nurten Aksoy
Journal:  Redox Rep       Date:  2016-02-18       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.